Predicting disease progression in patients with viable: Tumor at post-chemotherapy RPLND

被引:0
|
作者
Spiess, Philippe E.
Brown, Gordon A.
Tannir, Nizar M.
Tu, Shi-Ming
Liu, Ping
Kamat, Ashish M.
Wood, Christopher G.
Evans, James G.
Pisters, Louis L.
机构
来源
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词
D O I
10.1016/S0022-5347(18)31074-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:278 / 278
页数:1
相关论文
共 50 条
  • [41] Radiomic Analysis of Tumor Heterogeneity in HCC Post-Chemotherapy Using MRI
    Zhao, Q.
    MEDICAL PHYSICS, 2022, 49 (06) : E644 - E644
  • [42] Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer
    Famta, Paras
    Shah, Saurabh
    Jain, Naitik
    Kumar, Kondasingh Charan
    Bagasariya, Deepkumar
    Khatri, Dharmendra Kumar
    Raghuvanshi, Rajeev Singh
    Singh, Shashi Bala
    Srivastava, Saurabh
    LIFE SCIENCES, 2022, 310
  • [43] Management of post-chemotherapy residual masses in testicular tumor and surgical tecnique
    Ates, Ferhat
    Yilmaz, Omer
    Baykal, Kadir Vehbi
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (03): : 68 - 74
  • [44] RADIOTHERAPY FOR WILMS TUMOR: LONG-TERM OUTCOMES AND THERAPEUTIC IMPLICATIONS OF POST-CHEMOTHERAPY DISEASE STAGE
    Manjali, Jifmi
    Gowtham, K.
    Khanna, Nehal
    Mohan, Ram
    Parambil, Badira
    Panjwani, Poonam
    Shah, Sneha
    Patil, Vasundhara
    Baheti, Akshay
    Prasad, Maya
    Ramadwar, Mukta
    Chinnaswamy, Girish
    Qureshi, Sajid
    Laskar, Siddhartha
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S187 - S187
  • [45] Post-Chemotherapy Monocytopenia as a Predictor of Chemotherapy - Induced Neutropenia in Breast Cancer Patients
    Ardhiansyah, Azril Okta
    Manuaba, Ida Bagus Tjakra Wibawa
    Widiana, I. Ketut
    BALI MEDICAL JOURNAL, 2022, 11 (03) : 1325 - 1330
  • [46] Distinguishing fibrosis/necrosis from teratoma or viable disease in the retroperitoneum in post-chemotherapy, nonseminomatous testicular germ cell tumor using quantitative CT texture analysis.
    King, Kevin George
    Bhanvadia, Sumeet
    Ghodoussipour, Saum
    Hwang, Darryl
    Varghese, Bino
    Cen, Steven Yong
    Daneshmand, Siamak
    Duddalwar, Vinay
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [47] Post chemotherapy RPLND in patients with elevated markers: Current concepts and clinical outcome
    Beck, Stephen D. W.
    Foster, Richard S.
    Bihrle, Richard
    Einhorn, Lawrence H.
    Donohue, John P.
    UROLOGIC CLINICS OF NORTH AMERICA, 2007, 34 (02) : 219 - +
  • [48] PREDICTIVE CAPACITY OF MIRNA-375 IN IDENTIFYING TERATOMA IN POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND)
    Kenigsberg, Alexander
    Lafin, John
    Meng, Xiaosong
    Abe, Dreaux
    Savalyeva, Anna
    Singla, Nirmish
    Woldu, Solomon
    Lotan, Yair
    Kapur, Payal
    Margulis, Vitaly
    Amatruda, James
    Bagrodia, Aditya
    JOURNAL OF UROLOGY, 2020, 203 : E385 - E385
  • [49] Tumor marker levels in post-chemotherapy cystic masses: Clinical implications for patients with germ cell tumors
    Beck, SDW
    Patel, MI
    Sheinfeld, J
    JOURNAL OF UROLOGY, 2004, 171 (01): : 168 - 171
  • [50] Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
    Gerdtsson, Axel
    Torisson, Gustav
    Thor, Anna
    Bergdahl, Anna Grenabo
    Almas, Bjarte
    Hakansson, Ulf
    Tornblom, Magnus
    Negaard, Helene F. S.
    Glimelius, Ingrid
    Halvorsen, Dag
    Karlsdottir, Asa
    Haugnes, Hege Sagstuen
    Larsen, Signe Melsen
    Holmberg, Goran
    Wahlqvist, Rolf
    Tandstad, Torgrim
    Cohn-Cedermark, Gabriella
    Stahl, Olof
    Kjellman, Anders
    BJU INTERNATIONAL, 2023, 132 (03) : 329 - 336